Wegovy® (semaglutide injection) granted conditional marketing authorization for the treatment of non-cirrhotic metabolic dysfunction-associated ...

In patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced ...

While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...

Recent studies show that GLP-1 receptor agonists are associated with a significantly reduced risk of age-related cataracts ...

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...

For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

Bynes has been vocal about her weight-loss journey, which began in June with the trendy GLP-1 agonist drug Ozempic so she ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

The Institute for Advanced Reconstruction (IFAR) and The Plastic Surgery Center (TPSC) today announced the opening of a new 6,800-square-foot facility in Glen Rock, N.J., just 20 miles northwest of ...

According to the analysis, people who used GLP-1 medications had a 16 percent lower risk of developing epilepsy than those ...